Aropax Australia

NEW AROPAX BOOK

2011-04-10T09:34:00.001-07:00

My new book, 'The Evidence, However, Is Clear...The Seroxat Scandal' is now available as a paperback directly from the Chipmunka Publishing website. Copies can be ordered HERE

Price of the book is £10 - Postage from Chipmunka will be £2

The book will be available on Amazon in due course, unsure what the postage will be on Amazon.

Those who have expressed wishes to have the book signed can purchase directly from this blog. Please email me for details at fiddaman64@blueyonder.co.uk

If ordering direct from this blog, the postage to UK will be approx £2. For those overseas, I'll update on postage prices soon.

The Foreword is by Dr Jon Jureidini, child psychiatrist and clinical Professor, Discipline of Psychiatry, University of Adelaide, South Australia.

I owe Jon a great debt as it was he who set up the whole editing process [from Kindle version to paperback]

Here's his foreword.

Bob Fiddaman’s account of his interaction with the Medicines and Health Care Products Regulatory Agency (MHRA) over the antidepressant Seroxat (and of his blogging of that interaction) is comic and tragic in equal measures.

Charles Medawar, whose Antidepressant Web was godparent to Fiddaman’s blog, spoke of a ‘conspiracy of goodwill’ arising out of the wish of all parties (doctors, funders, manufacturers and users) that antidepressants be safe and effective. Fiddaman shows us that there is also ‘bad will’ in this case, identifying cynical and exploitative behaviour by those who we should be able to trust.

Around half of serious adverse affects of drugs are not identified until the medication has been used for a considerable time. This delay is understandable because research to bring a drug onto the market only involves hundreds or thousands of patients, whereas a successfully marketed drug will be taken by millions. Therefore rarer adverse effects sometimes do not become apparent for several years after a medication becomes widely available. By this time many may have been adversely affected by the drug without they or their doctors recognising that it is harmful. And when a drug is very widely prescribed (millions were taking Seroxat), every delay of a day in discovering harms means that thousands more people will suffer. Therefore pharmacovigilance (the detection and analysis of adverse effects of medications once they come into widespread use) has to be central to drug development and research if we are to reduce harm from medication.

But in spite of the fact that pharmaceutical companies have an obligation to monitor adverse effects of their drugs, they invest only a trivial sum in pharmacovigilance. Their priority is the much more profitable enterprise of developing and especially marketing new drugs, where they make huge investment. This imbalance is understandable (though not acceptable) in the light of their need to turn a profit, and reflects the lack of any significant disciplining of their activities by regulatory bodies.

One person’s reported experience with a drug proves little but Fiddaman shows us what we can learn when we collect together the experience of many users. Patients’ collective experiences with their drugs constitute a gold mine of information for the health system and pharmaceutical industry, but we doctors and scientist make barely any effort to collect the data and make sense of it. It is left to small heroes like Bob Fiddaman to irritate the system. A more rigorous and informative examination of patients’ experiences with drugs could prevent countless crippling adverse events. If we do ever achieve a truly effective system of pharmacovigilance, then Bob Fiddaman’s blog will have played an important part in this outcome.

Fid

**EXCLUSIVE VIDEO: LAWYERS DISCUSS THE RECENT GLAXO V KILKER CASE

2009-12-19T00:46:00.000-08:00

This is pretty riveting stuff - I only wish they could do this on national TV with an audience and I do hope that one day GlaxoSmithKline actually go the distance with an appeal and lose... instead of settling the case.

There are an awful amount of Internal documents from the Kilker case that have been sealed, they will remain sealed if Glaxo settle the appeal - which, they probably will.

Personally, I think this is appalling behaviour by GlaxoSmithKline. Lyam Kilker was born with heart defects [3 different heart defects as it happens] - A jury found GlaxoSmithKline's Paxil [Seroxat] to be the causation of his heart defects. Glaxo appeal the decision - yet settle other 'birth defect cases'. Meantime, the family of Lyam Kilker are plunged into another long wait which, I think, will result in an out of court settlement some time down the line.

It's one thing to manufacture a drug that harms a child, but to then punish the family and child because they won at trial is pretty despicable even by GlaxoSmithKline's standards.

Everyone, even GSK, have a right to appeal but we all know what the outcome of this tragic case is going to be - Glaxo will settle, they cannot afford for the sealed documents to be made public property.

My heart goes out to Lyam Kilker and his loving family. All his mother is guilty of is taken Paxil for what can only be deemed as mild depression. She never knew the damage it could cause her fetus because GlaxoSmithKline never told her... more importantly, they never told her doctor.

The case of Lyam Kilker was a 'test' case - basically Glaxo dipping their toes in the water to see how hot it is. It appears their toes were scolded.

Expect settlements with the other 630 birth defect cases they dispute.

Did they know of the dangers of pregnant women taking Paxil?

Watch the video.

The first 30 seconds is audio only, while the team prepare to go on air. The video is uncut and exclusive to Seroxat Sufferers blog.

Special thanks to the production team at Law Journal TV for passing this on to me and granting me permission to use on Seroxat Sufferers.

After watching the video, take a look at the files that have been made public from the recent Kilker v GSK trial, including a testimony from Ex-GSK executive Jane Nieman which was pretty damning for GlaxoSmithKline.

**Footnote

The MHRA have access to the documents. They refuse to act on them. A strong message of support for GlaxoSmithKline it would appear.

Fid

SEROXAT SUFFERERS STAND UP AND BE COUNTED
Beware of Obsessive freaks posting as me

Original Image: whitman-ma.gov

"This petition is to bring criminal charges against GlaxoSmithKline. The medication they made has caused numerous deaths not to mention birth defects. Many babies have died or been born with horrible birth defects caused by the use of Paxil [Seroxat]. Information that Paxil caused birth defects was hidden therefore taking the right to make an informed decision was taken away from Mothers. GlaxoSmithKline needs to be held criminally accountable for their misinformation and blantant lies. It is for all these babies to have justice."

SIGN THE PETITION HERE

JULY 2009 SSRI WITHDRAWAL GUIDE BY DAVID HEALY

KILKER v GLAXOSMITHKLINE COURT DOCUMENTS

2009-09-25T11:26:00.001-07:00

TO ACCESS FILES VISIT SEROXAT SUFFERERS BLOG HERE

----

Fid

SEROXAT SUFFERERS STAND UP AND BE COUNTED
Beware of Obsessive freaks posting as me.

Australia: Beyond Blue... Beyond Belief!

2009-04-17T05:15:00.000-07:00

I've been corresponding with an Australian author of late [Rebekah Beddoe] and we started musing over the help needed when withdrawing from SSRi's. Rebekah wrote a heart wrenching account of her time on a whole host of anti psychotic and antidepressant drugs, her book aptly entitled 'Dying For A Cure', is a terrific read and highlights the dangers of these drugs but more importantly the lack of knowledge the medical profession have regarding the addictive qualities and consequent tapering programs [or lack of] for patients.

Rebekah pointed me to Beyond Blue, an Australian organisation that provides information about depression to consumers, carers and health professionals. To be fair, I had heard of these before and have, in the past, visited their page. I seem to remember a conflict of interest regarding Beyond Blue but can't for the life of me remember whether I wrote it or read it elsewhere [my memory isn't what it used to be, thanks GSK]

Full article over at SEROXAT SUFFERERS BLOG

AROPAX AUSTRALIA

2007-09-02T23:46:00.000-07:00

For those who don't know Aropax is known as Paxil in the United States and Seroxat in the UK.

Australians have been pretty much kept in the dark about the dangers of this particular drug. It is my intention as author of the UK blog, Seroxat Sufferers, to help spread the word throughout Australia about the dangers of this drug. You owe it to yourselves to read the following blog and to spread the word to your family and friends. GlaxoSmithKline have had it their way for far too long. It's time to fight back!

Visit http://fiddaman.blogspot.com/ to read how GlaxoSmithKline concealed the trial results from the public. Learn of the Australian patient support groups who are sponsored by GlaxoSmithKline and tout the use of Aropax.

http://fiddaman.blogspot.com/
SEROXAT SUFFERERS

Other Aropax related blogs:
Blog - Big Pharma Victim
Blog - GSK Licence to (K) ill
Blog - Seroxat Kills Babies
Blog - Seroxat Secrets
Paxil Progress
Sharise Gatchell
THE SITE GSK THOUGHT THEY HAD CLOSED DOWN